Comparison

Mal-Deferoxamine European Partner

Item no. HY-132989-50mg
Manufacturer MedChem Express
CASRN 1638156-31-6
Amount 50 mg
Quantity options 100 mg 1 ea 25 mg 50 mg
Specific against other
Purity 95.0
Citations [1] Summer D, et al. Cyclic versus Noncyclic Chelating Scaffold for 89Zr-Labeled ZEGFR:2377 Affibody Bioconjugates Targeting Epidermal Growth Factor Receptor Overexpression. Mol Pharm. 2018;15(1):175-185.
Smiles O=C1C=CC(N1CCC(NCCCCCN(C(CCC(NCCCCCN(C(CCC(NCCCCCN(C(C)=O)O)=O)=O)O)=O)=O)O)=O)=O
Available
Product Description
Mal-Deferoxamine is the linker for construct RDC[1].
StorageTemperature
-20°C, 3 years (Powder)
Shipping
Blue Ice
Manufacturers Applications
Cancer-programmed cell death
MolecularWeight
711.80
Clinical Information
No Development Reported
Manufacturers Research Area
Cancer
Solubility
DMSO : 83.33 mg/mL (ultrasonic; warming; heat to 60°C)
Target
Others
Manufacturers Target
Others
Manufacturers Pathway
Others
Manufacturers Product type
Reference compound

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Amount: 50 mg
Available: In stock
available

Compare

Add to wishlist

Get an offer

Request delivery time

Ask a technical question

Submit a bulk request

Questions about this Product?
 
Close